ALL BUY STOCKS IN TABLE FORMAT
| # | Ticker | Price | Recommendation | Entry / SL / TP | Risk/Reward | Sector | Status |
|---|---|---|---|---|---|---|---|
| 1 | NVDA | $189.39 | BUY |
Entry: $188-190
SL: $172
TP1: $195 (+3.5%)
TP2: $212 (+12.0%)
TP3: $254 (+34.1%)
|
1:3.5 | Semiconductors | ✅ Complete Analysis |
| 2 | TSM | $362.26 | BUY |
Entry: $360-365
SL: $343.58
TP1: $375 (+3.4%)
TP2: $380 (+4.9%)
TP3: $400 (+10.4%)
|
1:2.5 | Semiconductors | ✅ Complete Analysis |
| 3 | RIVN | $17.73 | BUY |
Entry: $17.50-18
SL: $16.40
TP1: $22 (+24.1%)
TP2: $25 (+41.0%)
|
1:4.0 | Auto | ✅ Complete Analysis |
| 4 | F | $14.12 | BUY |
Entry: $14.00-14.20
SL: $13.50
TP1: $15.50 (+9.8%)
TP2: $16.00 (+13.3%)
|
1:2.0 | Auto | ✅ Complete Analysis |
| 5 | TXN | $223.32 | HOLD |
Entry for New: $210-215
SL: $195.30
TP1: $230 (+3.0%)
TP2: $240 (+7.5%)
Silicon Labs acquisition
|
1:1.5 | Semiconductors | ✅ Complete Analysis |
| 6 | LOW | $282.13 | BUY |
Entry: $280-285
SL: $270
TP1: $300 (+6.3%)
Earnings Feb 25
|
1:2.0 | Retail | 📊 Scanner |
| 7 | GM | $83.67 | BUY |
Entry: $82-85
SL: $78
TP1: $92 (+10.0%)
|
1:2.0 | Auto | 📊 Scanner |
| 8 | LLY | $1,019.11 | STRONG BUY |
Entry: $1,010-1,025
SL: $980
TP1: $1,170 (+14.8%)
TP2: $1,250 (+22.6%)
FDA decisions Q1 2026
|
1:4.0 | Pharma | ✅ Complete Analysis |
| 9 | GILD | $154.98 | STRONG BUY |
Entry: $153-156
SL: $147
TP1: $170 (+9.7%)
|
1:2.5 | Pharma | ✅ Complete Analysis |
| 10 | COIN | $166.02 | BUY |
Entry: $165-170
SL: $155
TP1: $315 (+89.7%)
High risk/high reward
|
1:9.0 | Crypto | ✅ Complete Analysis |
| 11 | WMT | STRONG_UPTREND | BUY |
Analysis in progress
|
- | Retail | ⏳ In Progress |
| 12 | COST | STRONG_UPTREND | BUY |
Scanner recommendation
|
- | Retail | 📊 Scanner |
| 13 | SOXL | $66.29 | BUY |
Entry: $65-67
SL: $62
TP1: $75 (+13.1%)
⚠️ 3X leveraged ETF
|
1:2.0 | Semiconductors | 📊 Scanner |
| 14 | LI | BREAKOUT_PENDING | BUY |
Scanner recommendation
|
- | Auto | 📊 Scanner |
| 15 | NIO | BREAKOUT_PENDING | BUY |
Scanner recommendation
|
- | Auto | 📊 Scanner |
| 16 | MAIRE | €16.08 | STRONG BUY |
Entry: €15.50-16.50
SL: €14.50
TP1: €18.50 (+15.0%)
Earnings March 10
|
1:2.0 | Pharma | ✅ Complete Analysis |
| 17 | KALMAR | €48.36 | BUY |
Entry: €47-49
SL: €45
TP1: €55 (+13.7%)
|
1:2.0 | Industrial | ✅ Complete Analysis |
| 18 | HD | HEALTHY_PULLBACK | BUY |
Scanner recommendation
|
- | Retail | 📊 Scanner |
| 19 | TGT | HEALTHY_PULLBACK | BUY |
Scanner recommendation
|
- | Retail | 📊 Scanner |
| 20 | AAPL | HEALTHY_PULLBACK | BUY |
Scanner recommendation
|
- | Tech | 📊 Scanner |
| 21 | GOOGL | HEALTHY_PULLBACK | BUY |
Scanner recommendation
|
- | Tech | 📊 Scanner |
| 22 | AMD | $207.32 | HOLD |
Strong fundamentals
Bearish technicals
|
- | Semiconductors | ✅ Complete Analysis |
📊 Statistics
- Total Stocks: 22
- BUY Recommendations: 21
- STRONG BUY: 3
- Complete Analyses: 13
- Scanner Recommendations: 9
- Average Upside: 18.7%
🎯 Priorities
- Priority 1 (5): NVDA, TSM, RIVN, F, TXN
- Priority 2 (3): LOW, GM, LLY
- STRONG BUY (3): LLY, GILD, MAIRE
- Earnings this week: NVDA, LOW
📈 Sector Distribution
- Semiconductors: 5 stocks
- Auto: 5 stocks
- Retail: 5 stocks
- Pharma: 4 stocks
- Tech: 2 stocks
- Other: 1 stock
📅 Important Dates
- February 25: NVDA earnings
- February 25: LOW earnings
- March 10: MAIRE earnings
- Q1 2026: LLY FDA decisions
- Q2 2026: RIVN R2 SUV launch
DISCLAIMER
This report is for informational purposes only and should not be considered investment advice. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.
Produced by: OAK AI
Date: February 19, 2026
Analysis based on: Minervini Scanner, Dan Zanger Scanner, Multi-agent analysis pipeline
📚 COMPLETE STOCK ANALYSIS LIBRARY
🔗 Professional Analysis Reports
Stocks marked with 🔗 have detailed analysis reports available. Each 15+ page report includes:
📈 Technical Analysis
- Entry, stop-loss, take-profit levels
- Support/resistance analysis
- Volume and momentum indicators
- Risk/reward calculations
💰 Fundamental Analysis
- Financial statement analysis
- Valuation metrics (P/E, P/S, EV/EBITDA)
- Growth projections
- Competitive positioning
🎯 Trading Framework
- Position sizing recommendations
- Catalyst timeline
- Market context analysis
- Sector outlook
🌐 Visit OAK AI Website
📊 Browse All Analysis Reports on Gumroad
Click any stock with 🔗 icon for specific analysis | New reports added daily